Prospective Assessment of Near-Infrared Spectroscopy for Left Ventricular Assist Devices

Overview

About this study

The purpose of this study is to use non-invasive sensing of cerebral perfusion to develop biomarkers of left ventricular assist devices (LVAD) patient outcome, avoiding de-listing of patients from the transplant list due to stroke occurrence.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults with left ventricular assist devices (LVAD) seen at Mayo clinic in Florida.

Exclusion Criteria:

Patients without LVAD.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 10/13/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Rohan Goswami, M.D.	Open for enrollment	Contact information: Rohan Goswami M.D. (904) 956-3272 Goswami.Rohan@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Rohan Goswami, M.D.

Open for enrollment

Contact information:

Rohan Goswami M.D.

(904) 956-3272

Goswami.Rohan@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials